SERS detects single molecules with exceptional sensitivity. To counter the issue of selectivity faced by point-of-care, herein, an externally applied electric field that allows electrical modulation and electromigrates unbound SERS tags without multiple washing steps is successfully developed and demonstrated to improve the biosensor's selectivity and sensitivity in multiplexed detection of cTnI, HDL, and LDL in human serum at a low LoD. Ultra-sensitive detectors can detect signals from non-specifically absorbed species, and these species can cover up overlapping analyte peaks, amplifying the effect of non-specific binding. Even though antifouling molecules can prevent non-specific adsorption at the sensor interface, this approach does not completely eliminate it. Our significant findings show that an electrically regulated device can electromigrate non-specifically bound species without cross-reacting with endogenous albumin proteins. Stability, repeatability, and reproducibility were good, with an RSD of 10%. Artificial intelligence was employed to interpret and analyze high-dimensional fingerprint SERS spectra using feature selection and dimensionality reduction for accurate acute myocardial infarction diagnosis and prognosis. These machine learning methods allow quantification of cTnI, HDL, and LDL biomarkers with low RMSE. Machine learning classifiers showed strong AUROC values of 0.950 ± 0.111 and 0.884 ± 0.139 for early and recurrent AMI detection, respectively. A high negative predictive value (NPV) of ≥99% indicates an effective early AMI rule-out. In short, this work demonstrated that a simple, low-cost, electrophoretic modulated biosensor with machine learning can diagnose, rule out, and predict recurring AMI.
Keywords: AI-Assisted; Acute myocardial infarction; Point-of-care; SERS; cardiac troponin.
Copyright © 2024 Elsevier B.V. All rights reserved.